Article Text

Download PDFPDF

CSF cytology versus immunocytochemistry in meningeal carcinomatosis.
  1. W Boogerd,
  2. T M Vroom,
  3. P van Heerde,
  4. G Brutel de la Rivière,
  5. J L Peterse,
  6. J J van der Sande
  1. Department of Neurology, The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis), Amsterdam.


    CSF immunocytochemistry with monoclonal antibodies was compared with conventional cytology to determine its sensitivity in detecting malignant cells in patients with meningeal carcinomatosis. One hundred and eighteen samples were investigated. Cytology was tumour positive in 83 samples and immunocytochemistry in 85. Dissimilar results between the two diagnostic methods were noted in 12 specimens, invariably occurring in samples with a low cell count and obtained from treated patients. Combined use of the two methods led to a 9% increase of sensitivity in detecting malignant cells compared with cytology alone. It is concluded that immunocytochemistry is of minor help in the problem of false-negative cytology in meningeal carcinomatosis.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.